Table I.

Characteristics of evaluable patients

Patient Characteristics (N=17)
Characteristics	No.	%
Age at Protocol Enrollment, years
Median	12.3
Range	4.3   20.0
Sex
Male	14	82.4
Female	3	17.6
Race
White	12	70.6
Black	3	17.6
Other	2	11.8
Diagnosis
Neuroblastoma	5	29.4
Wilms Tumor	3	17.6
Ewing Sarcoma	2	11.8
Nasopharyngeal carcinoma	2	11.8
Malignant Peripheral Nerve Sheath Tumor	1	5.9
Paraganglioma	1	5.9
Renal cell carcinoma	1	5.9
Chordoma	1	5.9
High-grade sarcoma	1	5.9
Prior Therapy
Chemotherapy Regimens (16 patients with prior chemotherapy)
Median	3
Range	1 – 5
Radiation	14	82.4